Use of the complement inhibitor Coversin to treat HSCT-associated TMA.
Sign Up to like & getrecommendations! Published in 2017 at "Blood advances"
DOI: 10.1182/bloodadvances.2016002832
Abstract: Finding an inherited complement abnormality in HSCT-associated TMA provides a rationale for the use of a complement inhibitor.Alternative complement inhibitors such as Coversin should be considered in patients who are resistant to eculizumab. read more here.
Keywords: complement inhibitor; complement; associated tma; hsct associated ... See more keywords